TC BioPharm (Holdings) PLC (TCBP)
1.39
+0.08
(+6.11%)
USD |
NASDAQ |
Nov 04, 16:00
1.41
+0.02
(+1.44%)
After-Hours: 20:00
TC BioPharm Shareholders Equity (Quarterly): 1.364M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.364M |
| June 30, 2023 | 2.532M |
| December 31, 2022 | 0.4009M |
| June 30, 2022 | 1.236M |
| Date | Value |
|---|---|
| December 31, 2021 | -22.35M |
| September 30, 2021 | -17.00M |
| December 31, 2020 | -4.562M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-22.35M
Minimum
Dec 2021
2.532M
Maximum
Jun 2023
-5.482M
Average
0.4009M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 96.27M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| Verona Pharma PLC | 168.27M |
| NuCana PLC | 4.806M |
| Autolus Therapeutics PLC | 527.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.171M |
| Total Liabilities (Quarterly) | 7.807M |